Nurix Therapeutics, Inc.
Clinical-stage biopharma developing protein degradation therapies for various diseases.
NRIX | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1700 OWENS STREET, SUITE 205, 94158 SAN FRANCISCO
- Website:
- https://www.nurixtx.com/
Description
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of medicines based on targeted protein degradation. The company's proprietary DEL-AI drug discovery engine is used to create therapies that harness the body's natural cellular machinery to eliminate disease-causing proteins. Its pipeline features multiple modalities, including small molecule degraders and Degrader Antibody Conjugates (DACs), which combine the specificity of an antibody with the catalytic potency of a degrader. These investigational therapies are being advanced for the treatment of various cancers and autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Nurix Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nurix Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nurix Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
